Literature DB >> 6436431

Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization.

B Ghebrehiwet, L Silvestri, C McDevitt.   

Abstract

We have shown previously that an activity which is capable of precipitating purified C1q and inhibiting some of the C1q-dependent biologic reactions could be solubilized from the membranes of both normal human peripheral B lymphocytes and a B cell-derived lymphoblastoid cell line (Raji), both of which are known to possess receptors for human C1q. In this report we present evidence that this membrane-associated C1q inhibitor is a chondroitinase-insensitive macromolecule and is the receptor for human C1q. The receptor was solubilized from membranes of Raji cells with Nonidet P-40 and purified to homogeneity using C1q-Sepharose 4B affinity chromatography. Equilibrium density gradient centrifugation analysis revealed that the complex could be resolved into a protein-rich, low density fraction and a carbohydrate-rich, high density fraction. The large hydrodynamic size, coupled with the high buoyant density, suggests that a proteoglycan is a constituent of the complex and indicates that the receptor might be a macromolecular complex of a proteoglycan portion noncovalently linked to a 60-70 kD glycoprotein. The glycoprotein moiety, in turn, consists of two or more identical (70,000 mol wt) polypeptide chains held together by disulfide bonds and constitutes the C1q receptor (C1qR). Sucrose density ultracentrifugation analysis showed that the isolated receptor sediments with an apparent rate of 4.2 S. Immunochemical analyses demonstrated that a typical preparation of the C1qR complex consists of approximately 23% uronic acid and approximately 21% galactosamine with a galactosamine-to-glucosamine ratio of 3.2. Binding of C1q to the receptor was found to be optimal at low ionic strength and neutral or near-neutral pH (7-7.4). The isolated receptor was found to inhibit C1q hemolytic function, abrogate C1q-dependent rosette formation, and block the C1q-dependent, cell-mediated cytotoxicity, all of which are activities mediated by the receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436431      PMCID: PMC2187510          DOI: 10.1084/jem.160.5.1375

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.

Authors:  K B Reid; R B Sim; A P Faiers
Journal:  Biochem J       Date:  1977-02-01       Impact factor: 3.857

Review 2.  Structure and activation of the early components of complement.

Authors:  R R Porter
Journal:  Fed Proc       Date:  1977-08

3.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

4.  Procedures for the automated analyses of proteoglycans and glycosaminoglycans.

Authors:  J D Ford; J R Baker
Journal:  Anal Biochem       Date:  1978-02       Impact factor: 3.365

5.  Dynamic aspects of the interaction between antibodies and complement at the cell surface.

Authors:  K G Sundqvist; S E Svehag; R T Thorstensson
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

6.  C1q protein of human complement.

Authors:  M A Calcott; H J Müller-Eberhard
Journal:  Biochemistry       Date:  1972-08-29       Impact factor: 3.162

7.  C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.

Authors:  E A Suba; G Csako
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

8.  Clq inhibition of the interaction of collagen with human platelets.

Authors:  J P Cazenave; S N Assimeh; R H Painter; M A Pachham; J F Mustard
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Lysis of C1Q-coated chicken erythrocytes by human lymphoblastoid cell lines.

Authors:  B Ghebrehiwet; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

10.  The structural basis for binding of complement by immunoglobulin M.

Authors:  M M Hurst; J E Volanakis; R B Hester; R M Stroud; J C Bennett
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  15 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  Role of platelet factors and serum complement in growth of fibroblasts with high-affinity Clq complement receptors.

Authors:  S Bordin; R C Page
Journal:  In Vitro Cell Dev Biol       Date:  1988-07

3.  Characterization of C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin.

Authors:  A Erdei; K B Reid
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

4.  A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.

Authors:  D K Galanakis; B Ghebrehiwet
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 5.  Collectins, collectin receptors and the lectin pathway of complement activation.

Authors:  R Malhotra; J Lu; U Holmskov; R B Sim
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

6.  Novel collectin/C1q receptor mediates mast cell activation and innate immunity.

Authors:  Brian T Edelson; Thomas P Stricker; Zhengzhi Li; S Kent Dickeson; Virginia L Shepherd; Samuel A Santoro; Mary M Zutter
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

7.  Chemical and hydrodynamic characterization of the human leucocyte receptor for complement subcomponent C1q.

Authors:  R Malhotra; R B Sim
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

8.  Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R.

Authors:  P Eggleton; B Ghebrehiwet; K N Sastry; J P Coburn; K S Zaner; K B Reid; A I Tauber
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity.

Authors:  Karissa D McCall-Culbreath; Zhengzhi Li; Mary M Zutter
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

10.  Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using iTRAQ and tandem mass spectrometry.

Authors:  Wei Li; Xuede Zhang; Wei Wang; Ruiying Sun; Boxuan Liu; Yuefeng Ma; Wei Zhang; Li Ma; Yaofeng Jin; Shuanying Yang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.